Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers

Fig. 7

Post-implant dosimetric quality assurance (QA) for a typical LDR BT treatment plan 1 month following implantation. Imaging the prostate (red) and rectum (blue) interface can be challenging on CT-guided post-implant QA. Isodose lines are shown as a percentage of the prescription dose (145 Gy). Sources are identified as green circles with upward-directed and downward-directed triangles representing out-of-plan sources. Treatment planning system is VariSeed 8.0 (Varian Inc. Palo Alto, CA, USA)

Back to article page